NCT03409016View on ClinicalTrials.gov

Biomarkers of Immune-Related Toxicity

Active, not recruitingOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

April 18, 2018

Primary Completion Date

May 28, 2025

Study Completion Date

May 28, 2026

Conditions
CancerMetastatic Cancer
Interventions
OTHER

Blood Testing

Patients will undergo therapy per standard protocol. There are no study-related medications or interventions beyond blood testing.

Trial Locations (1)

80045

University of Colorado Denver, Aurora

All Listed Sponsors
collaborator

Cancer League of Colorado

OTHER

lead

University of Colorado, Denver

OTHER

NCT03409016 - Biomarkers of Immune-Related Toxicity | Biotech Hunter | Biotech Hunter